- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Disease outbreaks.
Displaying page 1 of 1.
EudraCT Number: 2020-000926-24 | Sponsor Protocol Number: HTX101-03L | Start Date*: 2020-08-17 | ||||||||||||||||
Sponsor Name:Heidelberg ImmunoTherapeutics | ||||||||||||||||||
Full Title: A Randomised, Double-Blind Phase II Trial of Topical HDIT101 versus Placebo in Patients with Chronic Recurrent HSV-1 Infection and Orolabial Lesion | ||||||||||||||||||
Medical condition: Chronic Herpes Simplex Virus-1 Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) AT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-001622-64 | Sponsor Protocol Number: TAC-COVID19 | Start Date*: 2020-04-19 |
Sponsor Name:Dra Ana Pueyo Bastida | ||
Full Title: OUTPATIENT TREATMENT OF COVID-19 WITH EARLY PULMONARY CORTICOSTEROIDS AS AN OPPORTUNITY TO MODIFY THE COURSE OF THE DISEASE | ||
Medical condition: COVID-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-004015-21 | Sponsor Protocol Number: CA-P-3978-01 | Start Date*: 2006-08-31 | |||||||||||
Sponsor Name:Johnson & Johnson Consumer and Personal Products Worldwide | |||||||||||||
Full Title: Randomized Clinical Study Comparing Compeed Cold Sore Patch to Zovirax Cream 5% in the Treatment of Herpes Labialis | |||||||||||||
Medical condition: Herpes Labialis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000880-26 | Sponsor Protocol Number: HTX101-02G | Start Date*: 2019-09-03 | |||||||||||
Sponsor Name:Heidelberg ImmunoTherapeutics GmbH | |||||||||||||
Full Title: A Randomized, Double-Blind, Double-Dummy Phase II Study of Single Dose HDIT101 versus Standard of Care Valaciclovir in Patients with Chronic Recurrent Anogenital HSV-2 Infection | |||||||||||||
Medical condition: Chronic recurrent anogenital HSV-2 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
